Perinatal carcinogenesis: current directions. by Anderson, L. M. et al.
Br. J. Cancer (1991), 63, 1025 1028
Press Ltd., 1991
MEETING REPORT
Perinatal Carcinogenesis: Current Directions*
L.M. Anderson, A.B. Jones & J.M. Rice
Perinatal Carcinogenesis Section, Laboratory ofComparative Carcinogenesis, National Cancer Institute, Frederick Cancer
Research and Development Center, Frederick, Maryland 21702-1201, USA.
While perinatal animals exhibit unique sensitivity to carcino-
genesis, the extent to which perinatal human exposures con-
tribute to cancer risk remains largely unknown. Investigation
of this possibility is proceeding down four general avenues:
biochemical/molecular mechanisms of tumourigenesis in the
perinatal period; postnatal influences on prenatally initiated
neoplasms; study of specific perinatal human exposure situa-
tions with animal models; and the epidemiology of childhood
cancers. Investigators active in these areas presented their
current directions at this Workshop.
Biochemical/molecular mechanisms
Cytochrome P450-dependent metabolism ofcarcinogens
L. Anderson (National Cancer Institute, Frederick, MD)
summarised results from animal experiments confirming that
maternal and foetal metabolism of carcinogens clearly has
importance. Nitrosamines are metabolised poorly by most
rodent foetal tissues, at a maximum of about 15% of adult
levels, and in rats and mice nitrosamines are weakly effective
transplacentally. Polycyclic aromatic hydrocarbons (PAH),
by contrast, are often more potent in foetuses than adults. A
pharmacogenetic mouse model, wherein both mothers and
foetuses vary with regard to responsiveness to induction of
cytochrome P450 IAI, has demonstrated that both maternal
and foetal inducibility influence foetal tumourigenesis by a
PAH, with maternal inducibility reducing and foetal induci-
bility increasing risk. Human relevance is being studied using
the patas monkey foetomaternal system as a model. Aryl
hydrocarbon hydroxylase (AHH) activity increased in patas
maternal and foetal liver up to 5-fold after 50 mg benz-
pyrene kg-' and in placenta up to 100-fold. Monoclonal
antibody inhibitory effects indicate that most of the induced
activity was due to P450 IA1.
Continuing this theme, expression of cytochromes P450 in
developing human liver was addressed by T. Cresteil
(INSERUM U75, Paris, France). In adult human liver
amount of IA1 mRNA was extremely low and P450 IA1
protein was not detected in immunoblots. AHH was also
low; it correlated with amount of P450 IIC8. Human foetal
liver microsomes had AHH and IIC8 at -5% of adult
values. IA2 isoform seen in immunoblots of adult liver
microsomes showed a 20-fold variation among individuals. It
was absent from livers of foetuses and newborns, becoming
readily detectable only after 6 months and then at levels
much lower than adult. Acetanilide hydroxylase activity was
considerable in foetal liver, and in adults did not correlate
with P450 IA2 protein; it seems to mark another P450. AHH
and ethoxyresorufin dealkylase were elevated in placentas
from smokers, but little P450 IA2 detected by immunoblot.
Rodent and human cytochrome P450 orthologues may have
different reactivity toward common substrates; careful analy-
sis is needed for each substrate and human foetal or adult
enzyme.
DNA adducts and cellularfactors
What are the events and their consequences following
exposure of a foetal cell to activated carcinogen? L.-J.W. Lu
(U. of Texas Med. Branch, Galveston, TX) discussed
carcinogen-induced DNA adducts as biomarkers for assess-
ing perinatal risk and factors affecting the biologically
effective levels of metabolism-dependent carcinogens.
Chemical types affected DNA adduct levels, 4-Nitroquinoline
1-oxide, activated by reduction and conjugation, produced
much fewer adducts in foetal compared to adult tissues and
exhibited little gestation stage dependency or organ specificity
in DNA binding. This result contrasted with that observed
for benzo[a]pyrene (BP) which is activated by oxidation. BP
produced one major adduct, a guanine derivative of BP
diolepoxide I. The amounts of BP adducts in each foetal
organ increased as a function of gestation stage reflecting in
part the known ontogenetic development of cytochrome P-
450 mixed function oxidase. However, the patterns of in-
crease differed among the foetal organs tested. Additionally,
the relative amounts between corresponding maternal and
foetal organs or among the foetal organs were not predicted
from the activities of P-450 oxidases in these organs. BP also
produced high levels of BPDE-I derived guanine adducts in
foetal patas monkey tissues during at least the last 2/3 of
gestation, with stage dependency and levels no less than 1/3
maternal levels. Binding to foetal patas and mouse tissues
exhibited a tendency to peak before parturition, reflecting
perhaps ontogenetic appearance of phase II conjugation
enzymes, a kind of observation not predicted from study of
phase I activation enzymes alone. Collectively, DNA adduct
studies showed that foetal competence in metabolic activa-
tion is a critical determinant for risk. Foetal tissues (includ-
ing possibly human foetuses) may be at more risk to certain
types of chemical exposure than others.
Analysis of the cell proliferation factor was offered by D.
Branstetter (Upjohn Company, Kalamazoo, MI) based on
transplacental lung and liver tumorigenesis in C3H mice by
N-nitrosoethylurea (ENU), a direct-acting carcinogen pro-
ducing similar numbers of DNA adducts in foetal tissues
throughout gestation. Nevertheless, the numbers and sizes of
tumours induced vary markedly as a function of gestational
stage. Between days 10 and 16, the numbers of lung and liver
tumours initiated correlate highly with the number of dividing
cells. Plot of log tumour numbers vs gestation day yielded a
straight line, suggesting exposure of a logarhythmically-ex-
panding cell population. In addition, whereas lung tumours
initiated on day 15 are similar in size, after 6 months, to
those of adult-treated mice, those caused on gestation day 10
are much larger and multinodular. Similar results were
obtained for the sizes of liver adenomas and foci of
hepatocellular alteration: large multinodular lesions occurred
after initiation on day 10. This size difference may reflect
clonal expansion of the cell initiated early: plot of log tumour
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size vs gestation day of exposure gave a straight line. Popula-
tion doublings in the foetal target organs correlated with
differences in average tumour size. These inferences suggest
that an initiating hit received early in organogenesis may
have, in progeny, a more risky outcome than the same hit in
an adult, since proliferation of the affected cells may lead to
a population of preneoplastic cells at increased risk of
tumourigenesis due to subsequent hits or to promotional
stimuli, or to large tumours with increased probability of
malignant progression.
Oncogenes
Activation of cellular oncogenes may be part of the mecha-
nism of tumourigenesis in foetuses as well as in adults. J.
Rice (National Cancer Institute, Frederick, MD) described
transplacental activation of the neu oncogene in rat schwan-
nomas, which are common after transplacental exposure to
ENU. DNA from such tumours transformed mouse indicator
cells and DNA from transformants presented the rat neu
oncogene. Oligonucleotide probing revealed an activating
point mutation, a T to A transversion, in the transmembrane
domain of this oncogene in 46 of 49 schwaniomas. The neu
oncogene was also found in transplacentally-induced schwan-
nomas from hamsters and mice. The mutant allele is not
amplified, but is expressed at greater levels than the normal
allele; the latter may be suppressed. Efforts have been
initiated to examine activation of the human homologue of
neu, HER-2, in DNA of human schwannomas, from patients
with inherited neurofibromatosis disease. Thus far, the trans-
membrane sequences of six human tumours have been wild-
type. Reasons for the rarity of schwannomas in humans and
nonhuman primates are being investigated, with operation of
a primate-specific suppressor gene as one interesting possi-
bility.
H. Nakazawa (International Agency for Research on
Cancer, Lyon, France) compared activation of ras oncogene
in different tissues after transplacental 7,12-dimethylbenzan-
thracene (DMBA) in mice. A high percentage of skin papil-
lomas and carcinomas had mutations in the H-ras oncogene,
especially A to T transversion in codon 61. Transplacental
DMBA also increased the incidence and malignancy of liver
tumours, with the H-ras oncogene codon 61 muta-ion in
about 60%. The incidence of the oncogene mutation was
similar in liver tumours arising after DMBA followed by
postnatal treatment with the liver tumour promoter, pheno-
barbital (PB). Lung tumours instead showed mutated K-ras.
Clones of mutated cells present shortly after exposure were
identified by PCR amplification. By 2 weeks after birth, the
skin, liver, and lung all had both H-ras and K-ras mutations
at a rate of about 1 lo-. Similarly both H-ras and K-ras
mutations occurred in DMBA-treated NIH3T3 cells, even
though transformants eventually present mainly K-ras. Thus
both mutations happen, as might be predicted from thermo-
dynamic considerations, but which is recruited or expressed
for transformation is specific to the cell type.
P. Kleihues (University of Zurich, Switzerland) addressed
oncogene activation in tumours of the brain, common among
childhood cancers. Transforming genes have not been found
in gliomas induced by transplacental carcinogens. Therefore
another approach was tried: to introduce transforming genes
into the developing nervous system and to characterise the
neoplastic response of susceptible cell types. The oncogenes
were introduced using replication-deficient retroviral vectors,
incubated with a cell suspension from forebrain anlage of
foetal rats. The cells, subsequently transplanted into the
brain of syngeneic recipients, integrated well and underwent
abundant cell proliferation. After several months, spindle cell
tumours developed in 40% of the grafts infected with V-Ha-
ras. Immunohistochemistry revealed expression of S-100 pro-
tein but not GFAP, indicating glial origin though they did
not resemble oligodendrogliomas. While a viral gag-myc con-
struct produced only one tumour, with primative neuroec-
todermal cells and giant neurons, the combination of viral
ras and gag-myc was extremely effective, rapidly inducing
multiple rapidly-growing tumours, highly undifferentiated
and negative for all markers including GFAP. After several
passages in culture some did express GFAP upon retrans-
plantation, suggesting derivation from glial precursor cells.
Both oncogenes were strongly expressed in the tumour cells.
The ras-myc construct also efficiently transformed neural cells
in vitro, which upon transplantation produced a neoplasm
with architecture typical of primitive neuroectodermal
tumour of childhood. Transcripts of v-Ha-ras and V-myc or
p2lras protein were not detected in this tumour; insertional
mutagenesis of a growth-regulatory gene may have occurred.
Thus, retrovirus-mediated gene transfer into brain transplant
has demonstrated oncogene complementation in the nervous
system and a marked cell-specificity of activated oncogenes
for transformation of neural cells.
Postnatal influences on prenatally initiatedneoplasms
Positive and negative influence of postnatal factors on the
development of prenatally initiated neoplasms must be
understood for both risk assessment and for management of
exposed populations. B. Diwan (Program Resources, Inc.,
Frederick, MD) has investigated barbiturates, which promote
tumours in several epithelia of adult animals. To test this for
prenatally initiated tumours, four barbiturates were admini-
stered postnatally, barbital, barbituric acid, amobarbital, or
PB. ENU was given transplacentally to B10.A mice, a strain
sensitive to intestinal tumour induction. The incidence of
these was not influenced by postnatal treatment with any of
the barbiturates, but the number of thyroid neoplasms was
significantly increased by postnatal PB, and renal tubular
tumours increased 10-fold after postnatal barbital. None of
the barbiturates increased liver tumour incidence; PB decreas-
ed their number. In rats postnatal PB treatment did not
influence the most common tumours caused by transplacental
MNU, neurogenic and kidney, but did promote thyroid neo-
plasms and increase the number of preneoplastic liver lesions
in female offspring. The possible significance of such pheno-
mena for the human was emphasised, in light of the long
period of postnatal life.
Just as prenatally-initiated tumours may be later promot-
ed, it may be possible to suppress their appearance by
postnatal treatments. This subject was addressed by V. Alex-
androv (Petrov Institute of Oncology, Leningrad, USSR),
with a review of extensive screening studies for postnatal
inhibitors of transplacental carcinogenesis. The model was
transplacental ENU in rats, with nervous system and kidney
as the primary targets, followed by exposure throughout
postnatal life with a variety of extracts, chemicals and drugs.
Thiamine, retinol, a-tocopherol, and selenium, all with
chemopreventive actions in some animal models, were with-
out effect. Natural tissue factors, extracted from bovine
organs and known to influence immune system function,
showed promise: factors from thymus, pineal gland, and
brain all decreased tumour incidence and/or multiplicity in
many cases. Drugs, including the anti-inflammatory indo-
methacin, the antidiabetics phenformin and bleoformin, theo-
phylline, diazepam, dilantin and lithium, all suppressed the
numbers of one or more tumour type. Inhibition was also
observed with DFMO, an inhibitor of ornithine decarbox-
ylase; 8-aminocaproic acid; and fumaric (but not succinic)
acid; and some plant-derived chemicals. These survey results
open hope for postexposure inhibition ofhuman transplancen-
tal carcinogenesis, which may be especially critical for situa-
tions where known high exposure defines a high-risk
population.
Animal models for human exposure
Diethylstilbestrol
Interest continues in the mechanism of action and risk impli-
cations of the best-established human transplacental carcino-
gen, diethylstilbestrol (DES). J. McLachlan (National InstitutePERINATAL CARCINOGENESIS 1027
of Environmental Health Sciences, Research Triangle Park,
NC) reviewed some current ideas. The neonatal mouse is a
useful model, exhibiting stages of vaginal morphogenesis and
uterine differentiation comparable to the foetal human, and
susceptibility to DES causation of benign adenomatous
lesions and vaginal adenocarcinoma. Possible mechanisms
include cellular transformation vs response to altered hor-
monal milieu. DES and other oestrogens transform fibroblasts
in culture in the absence of any oestrogen-receptor mediated
effects, including enhanced cell proliferation. The role of
oestrogen receptors was studied with the neonatal mouse
model. Uterine tumours were induced by DES given neo-
natally, but not later, and required later oestrogen stimula-
tion for growth. Neonatal uterine epithelium contains nuclear
oestrogen receptors in only 10-20% of cells, and only those
cells respond to oestrogen with increased gene expression, but
oestrogen causes cells lacking oestrogen receptors to divide.
An interaction is postulated between oestrogen and epider-
mal growth factors (EGF): pro-EGF in the membranes of
uterine epithelial cells is processed to free ligand in response
to oestrogen and cell division ensues. Thus proliferation
may be stimulated in the absence of oestrogen receptor
before acquisition of differentiated characters; these may be
the target cells for oestrogen-mediated transformation. This
idea is being pursued by transfection of the oestrogen recep-
tor gene to fibroblasts in culture, and in transgenic mice
overexpressing growth factors in the uterus.
Implications of prenatal DES exposure for mammary
tumorigenesis were examined by E. Boylan (Queens College,
City University of New York) using the ACI rat. Prenatal
DES resulted in a dose-dependent incidence of tumours, and
the non-neoplastic mammary tissue presented a wider range
of expansion and morphological differentiation than normal,
with underdevelopment in some rats and proliferation in
others, especially those with tumours. Further experiments
attempted to distinguish between direct cellular effects of the
DES and those mediated hormonally. After a high trans-
placental dose of DES and ovariectomy, pellets containing
small amounts of DES or oestradiol, for local effect only,
were implanted adjacent to the mammary tissue and degree
of morphological differentiation scored. The implanted oes-
trogen stimulated differentiation, but to a lesser degree in
those rats that had been exposed to DES prenatally. Thus
mammary tissue of such rats was less responsive than controls
to the differentiation-enhancing action of directly-applied
oestrogen.
C. Lamartiniere (University of Alabama at Birmingham,
AL) has investigated the potential of neonatal DES to alter
CNS imprinting mechanisms and susceptibility for carcino-
genesis. Testosterone from foetal testes, aromatised in the
brain to oestrogen, establishes permanent, imprinted sex-
specific characteristics, including levels of hepatic enzymes.
Oestrogen from foetal ovaries is bound by a-foetoprotein to
prevent masculinisation of the brain. DES does not bind to
x-foetoprotein and so might alter these imprinting processes,
including an eventual effect on levels of carcinogen-metabo-
lising enzymes. This idea was tested in rats, using aflatoxin as
a liver carcinogen after neonatal DES and PB in the drinking
water as a liver tumour promoter. The incidences of liver
neoplasms after aflatoxin-PB exposure were slightly higher
in DES-pretreated vs control animals. An interesting unex-
pected finding was a 64% incidence of mammary lesions
(mainly lobular hyperplasias and fibroadenomas) in the afla-
toxin-PB treated females, but only 5% in those given DES
also. Additional studies are required to sort out relative
effects of the imprinting dose of DES on spontaneously-
arising tumours, on the metabolism of aflatoxin, and on
promotive effects of PB.
B. Walker (Michigan State University, East Lansing, MI)
considered both DES and maternal dietary fat effects on
tumours in offspring of female mice, with models involving
prenatal DES; prenatal DES exposure of the mothers; and
high dietary fat of mothers with or without their exposure as
foetuses to DES. Uterine and ovarian tumours were increas-
ing in offspring in all models, compared with controls. There
were also significantly more cervical tumours in those expos-
ed to DES prenatally, increased mammary tumour metastasis
after high maternal dietary fat, and more pituitary tumours
after DES or high fat. DES might act via direct somatic
mutation or by interference with hypothalamic imprinting
(see above). Experiments involving blastocyst transplantation
and limitation of the period of fat exposure are in progress to
reveal critical exposure times and shed light on the mecha-
nism of these effects.
NNK
A. Castonguay (Laval University, Quebec, Canada) sum-
marised data on the transplacental effects of the potent
tobacco-specific carcinogen NNK. For DNA damage and
tumourigenicity it requires metabolic activation, probably by
target tissue. He studied ability of foetal tissues to activate
NNK; transplacental passage of NNK; and transplacental
carcinogenicity. Lung and tracheal explants from foetal
hamsters catalysed a-carbon oxidation of NNK, an activat-
ing event, to an extent that increased with foetal age. Explant
DNA was methylated at the 06 position of guanine, a
promutagenic lesion. Foetal tissue homogenates incubated
with NNK and V79 cells caused an increase in the incidence
of NNK-caused micronuclei. Tracheal explants incubated
with NNK exhibited a dose-related squamous metaplasia.
After 500 mg kg-' to pregnant hamsters, both the compound
and two metabolites, NNAL and NNK-N-oxide were found
in foetal tissues, including binding to lung protein. After
intratracheal exposure, to model human smoking more close-
ly, the level of NNK was higher in amniotic fluid than in
maternal plasma and was clearly detectable in foetal lung
and liver. Evidence of in vivo genotoxic effects included
micronuclei in foetal liver and dose-related chromatid aberra-
tions in the epithelial cells of lung explants. There was a
dose-dependent transplacental carcinogenic effect, to a maxi-
mum 70% tumour incidence in the offspring, most often in
the respiratory tract. Finally, investigation of interactions
of NNK with alcohol indicated an influence on metabolism of
NNK in both maternal and foetal tissues.
Infiltrating angiolipoma ofskeletal muscle in primates
S. Rehm (National Cancer Institute, Frederick, MD) de-
scribed infiltrating angiolipoma in 35% of patas monkeys
exposed transplacentally to ENU for 12 weeks from gestation
day 30. These tumours occurred only after transplacental
treatment. The only other species in which they have been
described is the human, typically, young adults. The gross
and histological features of the tumours are similar in the
patas and in humans, with equal sex distribution, occurrence
at various locations, and contributions of blood vessels and
adipose tissue. While the mitotic rate may be low and metas-
tasis does not occur, they infiltrate skeletal muscle and can
become quite large. This may be a useful lead to epidemio-
logical follow-up.
Epidemiology
Epidemiology studies of perinatal carcinogenesis have focus-
ed on human childhood cancer. A. Olshan (University of
Pittsburg, PA) provided a summary overview. Since child-
hood cancer is relatively rare, recent studies have involved
case ascertainment from ongoing national collaborative clin-
ical trials conducted by the Children's Cancer Study Group
and the Pediatric Oncology Group. A recent case-control
study of Wilms' tumour confirmed increased risk for children
of fathers employed as vehicle mechanics, auto body repair-
ment, and welders. No association for maternal exposures
but a possible link with household insecticides were noted. A
case-control study of rhabdomyosarcoma found associations
with maternal occupation as health technicians, nurses, and
dental hygienists, diagnostic X-ray exposure during preg-
nancy, and parental use ofmarijuana or cocaine. In progress1028 L.M. ANDERSON et al.
are studies of: childhood Hodgkin's disease examining infec-
tious diseases as potential risk factors, including assays of
antibody levels in sera samples and of viral genome in histo-
logical samples; maternal use of nitrosatable drugs during
pregnancy and risk of childhood brain tumours; and the
contribution of paternal occupation, drug use during preg-
nancy, and electromagnetic field exposure on neuroblastoma,
including biological markers such as DNA ploidy, cytogen-
etics, and N-myc amplification.
G. Bunin (Children's Hospital, Philadelphia, PA) continu-
ed this theme with focus on retinoblastoma, thought to
involve two genetic mutations at the Rb locus. There are
three circumstances of occurrence: inheritence of a mutated
gene from a parent; sporadic heritable retinoblastoma, char-
acterised by bilateral tumour with no family history and
implying a new germline mutation; and nonheritable, pre-
sumably involving two somatic postconception mutations. A
case-control study with 201 pairs (9% with familial, 33%
with sporadic heritable, and 57% nonheritable cases) indi-
cated that paternal occupation in metal manufacturing,
particularly preconceptionally, was associated with sporadic
heritable disease. Paternal preconception military service also
correlated but not service in Southeast Asia or exposure to
dioxin. An occupational grouping including machinists,
welders, and other metal workers was associated with non-
heritable retinoblastoma, similarly for pre- and postconcep-
tion employment. Maternal grandparent's occupations were
also examined: a strong association was found between the
nonheritable retinoblastomas and grandparental occupation
as farmers. Stored body burdens of pesticides in the mothers
were suggested. Future plans include integration ofmolecular
biology with epidemiology, for example, examination of
specific changes in the retinoblastoma gene as related to
paternal exposures.
Comments
A purpose of this Workshop was to clarify goals of the
perinatal carcinogenesis field, and to this end some common
themes emerged. (1) The time is past for narrow, self-con-
tained dissection of phenomenology. Animal models should
be relating to specific human cancer questions, especially
ones that are not easily addressable by application of
molecular biology to human material. Consideration of
molecular/biochemical factors should ideally be done side-by-
side with human and rodent material, and since human
material is often unobtainable, nonhuman primates may be
particularly valuable in this regard. (2) Epidemiologists on
the other hand should be working from thorough, detailed
knowledge of animal model results, and more frequent dia-
logue between epidemiologists and experimentalists is needed.
(3) The extent to which perinatal exposures influence inci-
dence of adult-type cancers in humans remains an unplumb-
ed but very important question. Interaction of oncogenic
agents with the immature cells of the perinate would be
expected to yield the typical undifferentiated tumours of
childhood. On the other hand, in rodents, transplacentally-
initiated tumours are often morphologically similar to those
caused in adults; tumours caused by low, environmental
levels of carcinogen might have long latency; and results with
DES or high fat exposure during pregnancy, and data on
postnatal promoters and inhibitors, suggest persistent
changes, some of them subtle, that can continue to be played
upon by other influences throughout postnatal life. This
question, of origin of typical aging-related human cancers
from perinatal exposures, is a challenge for epidemiologists
for obvious reasons; additional, carefully planned work with
animals could help guide their efforts.